Ned N. Fleming IV, Senior Vice President of Strategy and Business Development at Construction Partners, Inc. (NASDAQ:ROAD), filed a Form 4 on November 6, 2026, disclosing multiple transactions in Class A Common Stock dated November 4, 2026.
Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in Gabelli Healthcare & WellnessRx Trust on November 5, 2026.
William J. Peters, CFO, EVP, and Treasurer of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), filed a Form 4 on November 6, 2026, disclosing option exercises and open-market sales of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
Director Noreen E. Skelly filed a Form 4 with the SEC on November 6, 2026, disclosing a purchase of 100 shares of Construction Partners, Inc. Class A Common Stock on that same date.
Construction Partners, Inc. President and CEO Fred Julius Smith III filed a Form 4 on November 6, 2026, disclosing three Class A common stock transactions dated November 4, 2026, including a restricted share grant, a PSU settlement, and a tax-withholding share surrender.
Gregory A. Hoffman, SVP and Chief Financial Officer of Construction Partners, Inc. (NASDAQ:ROAD), filed a Form 4 on November 6, 2026, disclosing three transactions in Class A common stock on November 4, 2026, including a restricted share grant, a PSU settlement, and a tax-withholding …
Robert G. Baugnon, Senior Vice President of Personnel and Administration at Construction Partners, Inc., filed a Form 4 on November 6, 2026, reporting three transactions in Class A common stock on November 4, 2026, including a restricted share grant, a PSU settlement, and a …
Construction Partners, Inc. SVP and General Counsel Judson Ryan Brooks filed a Form 4 on November 6, 2026, reporting three transactions in Class A common stock that occurred on November 4, 2026, including a restricted stock award grant, a PSU settlement, and a share …
Director John H. Irby of Pinnacle Financial Partners, Inc. filed a Form 4 on November 6, 2026, disclosing a gift of 1,500 shares of common stock on November 5, 2026, at a price of $0.
Royalty Pharma plc EVP Marshall Urist filed a Form 4 on November 6, 2026, disclosing two transactions dated November 4 and November 6, 2026, involving the acquisition of Class A Ordinary Shares and an exchange of limited partnership interests in RPI US Partners 2019, …